Literature DB >> 25491670

Biodistribution of PLGA and PLGA/chitosan nanoparticles after repeat-dose oral delivery in F344 rats for 7 days.

Sara M Navarro1, Caleb Darensbourg, Linda Cross, Rhett Stout, Diana Coulon, Carlos E Astete, Timothy Morgan, Cristina M Sabliov.   

Abstract

AIM: To quantify in vivo the biodistribution of poly(lactic-co-glycolic) acid (PLGA) and PLGA/chitosan nanoparticles (PLGA/Chi NPs) and assess if the positive charge of chitosan significantly enhances nanoparticle absorption in the GI tract. MATERIAL &
METHODS: PLGA and PLGA/Chi NPs covalently linked to tetramethylrhodamine-5-isothiocyanate (TRITC) were orally administered to F344 rats for 7 days, and the biodistribution of fluorescent NPs was analyzed in different organs.
RESULTS: The highest amount of particles (% total dose/g) was detected for both treatments in the spleen, followed by intestine and kidney, and then by liver, lung, heart and brain, with no significant difference between PLGA and PLGA/Chi NPs.
CONCLUSION: Only a small percentage of orally delivered NPs was detected in the analyzed organs. The positive charge conferred by chitosan was not sufficient to improve the absorption of the PLGA/Chi NPs over that of PLGA NPs.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25491670      PMCID: PMC4451574          DOI: 10.4155/tde.14.79

Source DB:  PubMed          Journal:  Ther Deliv        ISSN: 2041-5990


  35 in total

1.  Effect of chitosan on epithelial cell tight junctions.

Authors:  Jennifer Smith; Edward Wood; Michael Dornish
Journal:  Pharm Res       Date:  2004-01       Impact factor: 4.200

2.  Effects of protein binding on the biodistribution of PEGylated PLGA nanoparticles post oral administration.

Authors:  Boitumelo Semete; Laetitia Booysen; Lonji Kalombo; Bathabile Ramalapa; Rose Hayeshi; Hulda S Swai
Journal:  Int J Pharm       Date:  2011-12-30       Impact factor: 5.875

3.  Antacid co-encapsulated polyester nanoparticles for peroral delivery of insulin: development, pharmacokinetics, biodistribution and pharmacodynamics.

Authors:  G Sharma; C F van der Walle; M N V Ravi Kumar
Journal:  Int J Pharm       Date:  2011-12-30       Impact factor: 5.875

4.  In vivo uptake and acute immune response to orally administered chitosan and PEG coated PLGA nanoparticles.

Authors:  B Semete; L I J Booysen; L Kalombo; J D Venter; L Katata; B Ramalapa; J A Verschoor; H Swai
Journal:  Toxicol Appl Pharmacol       Date:  2010-09-17       Impact factor: 4.219

5.  The prolongation of the lifespan of rats by repeated oral administration of [60]fullerene.

Authors:  Tarek Baati; Fanchon Bourasset; Najla Gharbi; Leila Njim; Manef Abderrabba; Abdelhamid Kerkeni; Henri Szwarc; Fathi Moussa
Journal:  Biomaterials       Date:  2012-04-10       Impact factor: 12.479

6.  PLGA nanoparticles of different surface properties: preparation and evaluation of their body distribution.

Authors:  Farnaz Esmaeili; Mohammad Hossein Ghahremani; Behnaz Esmaeili; Mohammad Reza Khoshayand; Fatemeh Atyabi; Rassoul Dinarvand
Journal:  Int J Pharm       Date:  2007-08-06       Impact factor: 5.875

Review 7.  Clearance properties of nano-sized particles and molecules as imaging agents: considerations and caveats.

Authors:  Michelle Longmire; Peter L Choyke; Hisataka Kobayashi
Journal:  Nanomedicine (Lond)       Date:  2008-10       Impact factor: 5.307

8.  Effect of molecular structure of cationic surfactants on biophysical interactions of surfactant-modified nanoparticles with a model membrane and cellular uptake.

Authors:  Chiranjeevi Peetla; Vinod Labhasetwar
Journal:  Langmuir       Date:  2009-02-17       Impact factor: 3.882

9.  Distribution of silver in rats following 28 days of repeated oral exposure to silver nanoparticles or silver acetate.

Authors:  Katrin Loeschner; Niels Hadrup; Klaus Qvortrup; Agnete Larsen; Xueyun Gao; Ulla Vogel; Alicja Mortensen; Henrik Rye Lam; Erik H Larsen
Journal:  Part Fibre Toxicol       Date:  2011-06-01       Impact factor: 9.400

10.  Employment of a noninvasive magnetic method for evaluation of gastrointestinal transit in rats.

Authors:  Caio C Quini; Madileine F Américo; Luciana A Corá; Marcos Ff Calabresi; Matheus Alvarez; Ricardo B Oliveira; Jose Ricardo A Miranda
Journal:  J Biol Eng       Date:  2012-05-15       Impact factor: 4.355

View more
  6 in total

1.  Antifungal Activity of Chitosan-Coated Poly(lactic-co-glycolic) Acid Nanoparticles Containing Amphotericin B.

Authors:  Daniel Brustolin Ludwig; Luciana Erzinger Alves de Camargo; Najeh Maissar Khalil; Marcos Ereno Auler; Rubiana Mara Mainardes
Journal:  Mycopathologia       Date:  2018-03-01       Impact factor: 2.574

2.  SP94-Targeted Triblock Copolymer Nanoparticle Delivers Thymidine Kinase-p53-Nitroreductase Triple Therapeutic Gene and Restores Anticancer Function against Hepatocellular Carcinoma in Vivo.

Authors:  Uday K Sukumar; Jagadesh Chandra Bose Rajendran; Sanjiv S Gambhir; Tarik F Massoud; Ramasamy Paulmurugan
Journal:  ACS Appl Mater Interfaces       Date:  2020-03-02       Impact factor: 9.229

3.  Distinct Proteins in Protein Corona of Nanoparticles Represent a Promising Venue for Endogenous Targeting - Part II: In vitro and in vivo Kinetics Study.

Authors:  Aya Ahmed Sebak; Iman Emam Omar Gomaa; Aliaa Nabil ElMeshad; Mahmoud Hussien Farag; Ulrike Breitinger; Hans-Georg Breitinger; Mahmoud Hashem AbdelKader
Journal:  Int J Nanomedicine       Date:  2020-11-30

4.  Formulation and In vitro Interaction of Rhodamine-B Loaded PLGA Nanoparticles with Cardiac Myocytes.

Authors:  Antranik Jonderian; Rita Maalouf
Journal:  Front Pharmacol       Date:  2016-12-06       Impact factor: 5.810

Review 5.  Bioavailability of Orally Delivered Alpha-Tocopherol by Poly(Lactic-Co-Glycolic) Acid (PLGA) Nanoparticles and Chitosan Covered PLGA Nanoparticles in F344 Rats.

Authors:  Lacey C Simon; Rhett W Stout; Cristina Sabliov
Journal:  Nanobiomedicine (Rij)       Date:  2016-01-01

6.  Mitigation of Tacrolimus-Associated Nephrotoxicity by PLGA Nanoparticulate Delivery Following Multiple Dosing to Mice while Maintaining its Immunosuppressive Activity.

Authors:  Aws Alshamsan; Ziyad Binkhathlan; Mohd Abul Kalam; Wajhul Qamar; Hala Kfouri; Mohammed Alghonaim; Afsaneh Lavasanifar
Journal:  Sci Rep       Date:  2020-04-21       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.